Statistics for Inozyme Pharma, (id:8179 INZY)
Valuation metrics
Market cap
172.81M
Enterprise value
94.41M
Trailing P/E (ttm)
-2.05
Forward P/E
-1.66
PEG ratio
-1.66
Price/Sales (ttm)
Price/Book (mrq)
2.09
Enterprise Value/Revenue
Enterprise Value/EBITDA
-0.96
Overview
Shares outstanding
64.24M
Float
36.52M
Shares short
3.23M
% Held by insiders
0.01%
% Held by institutions
0.97%
Average volume (10 days)
373.60K
Average volume (90 days)
Price summary
52-Week low
2.61
52-Week high
7.80
52-Week change
-32.38%
Beta
1.54
50-Day moving average
4.79
200-Day moving average
5.11
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-35.69%
Return on equity
-79.42%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-98,893,000.00
Net income to common (ttm)
-96,494,000.00
Diluted EPS (ttm)
-1.55
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
131.61M
Total cash per share (mrq)
2.05
Total debt (mrq)
46.79M
Total Debt/Equity (mrq)
56.52
Current ratio (mrq)
768.30%
Book value per share (mrq)
1.29
Cash flow
Cash flow statement
-91,206,000.00
Levered free cash flow (LFCF)
-55,929,500.00